Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-17-007595)

Filing Details

Accession Number:: 0001171843-17-007595
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-11 17:30:22
Reporting Period:: 2017-12-07

Accepted Time:: 2017-12-11 17:30:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328146	A Peter Kiener	805 King Farm Blvd, Suite 550 Rockville MD 20850	Chief Science Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Class A	Acquisiton	2017-12-07	50,000	$8.33	52,023	No	4	M	Direct
Common Stock, Class A	Disposition	2017-12-07	50,000	$16.50	2,023	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Employee Stock Option (right to buy)	Disposition	2017-12-07	50,000	$0.00	50,000	$8.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
242,567		2024-10-27	No	4	M	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
Multiple lots for the same price for this order have been combined.
Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.